Role of diet on non-alcoholic fatty liver disease: An updated narrative review

被引:39
作者
Papandreou, Dimitrios [1 ]
Andreou, Eleni [2 ]
机构
[1] Zayed Univ, Dept Nat Sci & Publ Hlth, CSSH, Abu Dhabi 144534, U Arab Emirates
[2] Univ Nicosia, Dept Life & Hlth Sci, Nicosia 1700, Cyprus
关键词
Diet; Non-alcoholic fatty acids; Fatty acids; Obesity; Insulin resistance;
D O I
10.4254/wjh.v7.i3.575
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of this article review is to update what is known about the role of diet on non-alcoholic fatty liver disease (NAFLD). NAFLD is the most common cause of chronic liver disease in the developed world and is considered to be a spectrum, ranging from fatty infiltration of the liver alone (steatosis), which may lead to fatty infiltration with inflammation known as non alcoholic steatohepatitis While the majority of individuals with risk factors like obesity and insulin resistance have steatosis, only few people may develop steatohepatitis. Current treatment relies on weight loss and exercise, although various insulin-sensitizing medications appear promising. Weight loss alone by dietary changes has been shown to lead to histological improvement in fatty liver making nutrition therapy to become a cornerstone of treatment for NAFLD. Supplementation of vitamin E, C and omega 3 fatty acids are under consideration with some conflicting data. Moreover, research has been showed that saturated fat, trans-fatty acid, carbohydrate, and simple sugars (fructose and sucrose) may play significant role in the intrahepatic fat accumulation. However, true associations with specific nutrients yet to be clarified.
引用
收藏
页码:575 / 582
页数:8
相关论文
共 85 条
  • [1] Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease
    Alkhouri, Naim
    De Vito, Rita
    Alisi, Anna
    Yerian, Lisa
    Lopez, Rocio
    Feldstein, Ariel E.
    Nobili, Valerio
    [J]. JOURNAL OF HEPATOLOGY, 2012, 57 (06) : 1312 - 1318
  • [2] HEPATIC-EFFECTS OF DIETARY WEIGHT-LOSS IN MORBIDLY OBESE SUBJECTS
    ANDERSEN, T
    GLUUD, C
    FRANZMANN, MB
    CHRISTOFFERSEN, P
    [J]. JOURNAL OF HEPATOLOGY, 1991, 12 (02) : 224 - 229
  • [3] Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review
    Arab, Juan P.
    Candia, Roberto
    Zapata, Rodrigo
    Munoz, Cristian
    Arancibia, Juan P.
    Poniachik, Jaime
    Soza, Alejandro
    Fuster, Francisco
    Brahm, Javier
    Sanhueza, Edgar
    Contreras, Jorge
    Carolina Cuellar, M.
    Arrese, Marco
    Riquelme, Arnoldo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (34) : 12182 - 12201
  • [4] Are statins 'IDEAL' for non-alcoholic fatty liver disease?
    Athyros, Vasilios G.
    Katsiki, Niki
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (02) : 229 - 231
  • [5] Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
    Athyros, Vasilios G.
    Tziomalos, Konstantinos
    Gossios, Thomas D.
    Griva, Theodora
    Anagnostis, Panagiotis
    Kargiotis, Konstantinos
    Pagourelias, Efstathios D.
    Theocharidou, Eleni
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. LANCET, 2010, 376 (9756) : 1916 - 1922
  • [6] IDIOPATHIC STEATOHEPATITIS IN CHILDHOOD - A MULTICENTER RETROSPECTIVE STUDY
    BALDRIDGE, AD
    PEREZATAYDE, AR
    GRAEMECOOK, F
    HIGGINS, L
    LAVINE, JE
    [J]. JOURNAL OF PEDIATRICS, 1995, 127 (05) : 700 - 704
  • [7] Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population
    Bertolotti, Marco
    Mussi, Chiara
    Pellegrini, Elisa
    Magni, Alessandro
    Del Puppo, Marina
    Ognibene, Silvia
    Carulli, Lucia
    Anzivino, Claudia
    Baldelli, Enrica
    Loria, Paola
    Carulli, Nicola
    [J]. CLINICAL INTERVENTIONS IN AGING, 2014, 9 : 425 - 432
  • [8] Mortality in randomized trials of antioxidant supplements for primary and secondary prevention - Systematic review and meta-analysis
    Bjelakovic, Goran
    Nikolova, Dimitrinka
    Gluud, Lise Lotte
    Simonetti, Rosa G.
    Gluud, Christian
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (08): : 842 - 857
  • [9] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [10] Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study
    Capanni, M
    Calella, F
    Biagini, MR
    Genise, S
    Raimondi, L
    Bedogni, G
    Svegliati-Baroni, G
    Sofi, F
    Milani, S
    Abbate, R
    Surrenti, C
    Casini, A
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1143 - 1151